Etsuko Yamazaki

No ORCID on file · 1 paper in corpus

observational 2025

Assessment of tissue factor pathway inhibitor 2 (TFPI2) as a novel serum marker for malignant tumors of the ovary before and after treatment: A case-control study

The journal of obstetrics and gynaecology research ·doi:10.1111/jog.16241

AIM: Tissue factor pathway inhibitor 2 (TFPI2) is a preoperative biomarker that was developed to discriminate ovarian benign tumors from cancer and is covered by health insurance in Japan. The purpose of this study was to evaluate how the T…